Summary & Overview
CPT 80368: Non‑benzodiazepine Sedative Hypnotic Testing
CPT code 80368 designates laboratory testing to detect or quantify non–benzodiazepine sedative hypnotics in patient specimens. These assays support clinical decisions in settings where confirmation of exposure, therapeutic monitoring, or toxicology screening is required. Nationally, such testing matters for emergency care, perioperative management, substance use evaluation, and forensic or workplace testing contexts.
Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of what the code represents, typical clinical scenarios and sites of service, and the types of benchmarks and policy considerations usually associated with clinical toxicology codes. The publication outlines common billing modifiers and payer coverage patterns where available, plus comparisons to related laboratory toxicology services.
This summary provides clinical context for coding and billing teams, laboratory managers, and compliance officers. It highlights where CPT code 80368 is used in practice and orients readers to the policy and reimbursement issues they should expect when arranging, performing, or billing non–benzodiazepine sedative hypnotic testing. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 80368 describes a laboratory test in which a lab analyst measures the amount of or detects the presence of non–benzodiazepine sedative hypnotics in a patient specimen. This is a clinical toxicology service focused on identifying and quantifying commonly used non-benzodiazepine sleep medications and sedative agents.
Service type: Clinical toxicology / laboratory drug testing
Typical site of service: Clinical laboratory or hospital laboratory; specimen collection may occur in outpatient clinics, emergency departments, or inpatient settings
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 34-year-old patient presents to the emergency department after a motor vehicle collision with concerns for altered mental status and possible impaired consciousness. The treating clinician orders toxicology testing to identify the presence of sedative-hypnotic agents that are not benzodiazepines (for example zolpidem, zaleplon, eszopiclone) to guide acute management and disposition. A blood or urine specimen is collected and sent to the hospital laboratory. The lab analyst performs an assay to detect or quantify non-benzodiazepine sedative hypnotics and reports results to the ordering clinician. Typical site of service is a hospital clinical laboratory or independent medical laboratory supporting emergency department, inpatient, and outpatient clinic testing. The workflow includes specimen collection, accessioning, analytical testing (immunoassay or confirmatory mass spectrometry), result verification by a laboratory professional, and electronic reporting to the medical record and ordering clinician for clinical decision-making and case documentation.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the professional interpretation/analysis portion if the lab separates technical and professional components. |
TC |